Sartorius Financial Statements From 2010 to 2024
| DIM Stock | EUR 175.00 6.40 3.80% |
Check Sartorius Stedim financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sartorius Stedim's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sartorius financial statements analysis is a perfect complement when working with Sartorius Stedim Valuation or Volatility modules.
Sartorius |
Sartorius Stedim Biotech Company Operating Margin Analysis
Sartorius Stedim's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Sartorius Stedim Operating Margin | 0.32 % |
Most of Sartorius Stedim's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sartorius Stedim Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Sartorius Stedim Biotech has an Operating Margin of 0.3196%. This is 100.91% lower than that of the Healthcare sector and 106.81% lower than that of the Medical Instruments & Supplies industry. The operating margin for all France stocks is 105.8% lower than that of the firm.
Sartorius Stedim Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sartorius Stedim's current stock value. Our valuation model uses many indicators to compare Sartorius Stedim value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sartorius Stedim competition to find correlations between indicators driving Sartorius Stedim's intrinsic value. More Info.Sartorius Stedim Biotech is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.37 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sartorius Stedim Biotech is roughly 2.68 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sartorius Stedim by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sartorius Stedim's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Sartorius Stedim Financial Statements
Sartorius Stedim stakeholders use historical fundamental indicators, such as Sartorius Stedim's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sartorius Stedim investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sartorius Stedim's assets and liabilities are reflected in the revenues and expenses on Sartorius Stedim's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sartorius Stedim Biotech. Please read more on our technical analysis and fundamental analysis pages.
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. SARTORIUS STED operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 10409 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sartorius Stock
Sartorius Stedim financial ratios help investors to determine whether Sartorius Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Stedim security.